Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
[Insomnia in the menopause]
Yu V Shkurenko1, A D Ibatov1, T D Kapyrina1
1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Abstract:
During the menopause transition, pathogenetic changes begin to occur in the reproductive system and they affect the quality of sleep and contribute to the development of insomnia. Given the multifactorial nature of insomnia and the special characteristics of its pathogenesis, it is necessary to adhere to an integrated approach in the treatment of patients of the older age group. In our opinion, if we have indications, a promising direction for the treatment of sleep disorders during period of menopausal syndrome is the use of hormone replacement therapy in addition to traditional methods of the treatment of insomnia.
Related Concept Videos
Menopause
Insomnia
Multiple factors contribute...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Narcolepsy

